Skip to main content
Journal cover image

Serum Metabolites Are Associated With HFpEF in Biopsy-Proven Nonalcoholic Fatty Liver Disease.

Publication ,  Journal Article
Wegermann, K; Fudim, M; Henao, R; Howe, CF; McGarrah, R; Guy, C; Abdelmalek, MF; Diehl, AM; Moylan, CA
Published in: J Am Heart Assoc
July 18, 2023

Background Nonalcoholic fatty liver disease (NAFLD) and heart failure with preserved ejection fraction (HFpEF) share common risk factors, including obesity and diabetes. They are also thought to be mechanistically linked. The aim of this study was to define serum metabolites associated with HFpEF in a cohort of patients with biopsy-proven NAFLD to identify common mechanisms. Methods and Results We performed a retrospective, single-center study of 89 adult patients with biopsy-proven NAFLD who had transthoracic echocardiography performed for any indication. Metabolomic analysis was performed on serum using ultrahigh performance liquid and gas chromatography/tandem mass spectrometry. HFpEF was defined as ejection fraction >50% plus at least 1 echocardiographic feature of HFpEF (diastolic dysfunction, abnormal left atrial size) and at least 1 heart failure sign or symptom. We performed generalized linear models to evaluate associations between individual metabolites, NAFLD, and HFpEF. Thirty-seven out of 89 (41.6%) patients met criteria for HFpEF. A total of 1151 metabolites were detected; 656 were analyzed after exclusion of unnamed metabolites and those with >30% missing values. Fifty-three metabolites were associated with the presence of HFpEF with unadjusted P value <0.05; none met statistical significance after adjustment for multiple comparisons. The majority (39/53, 73.6%) were lipid metabolites, and levels were generally increased. Two cysteine metabolites (cysteine s-sulfate and s-methylcysteine) were present at significantly lower levels in patients with HFpEF. Conclusions We identified serum metabolites associated with HFpEF in patients with biopsy-proven NAFLD, with increased levels of multiple lipid metabolites. Lipid metabolism could be an important pathway linking HFpEF to NAFLD.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Heart Assoc

DOI

EISSN

2047-9980

Publication Date

July 18, 2023

Volume

12

Issue

14

Start / End Page

e029873

Location

England

Related Subject Headings

  • Stroke Volume
  • Retrospective Studies
  • Non-alcoholic Fatty Liver Disease
  • Lipids
  • Humans
  • Heart Failure
  • Cysteine
  • Biopsy
  • Adult
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wegermann, K., Fudim, M., Henao, R., Howe, C. F., McGarrah, R., Guy, C., … Moylan, C. A. (2023). Serum Metabolites Are Associated With HFpEF in Biopsy-Proven Nonalcoholic Fatty Liver Disease. J Am Heart Assoc, 12(14), e029873. https://doi.org/10.1161/JAHA.123.029873
Wegermann, Kara, Marat Fudim, Ricardo Henao, Catherine F. Howe, Robert McGarrah, Cynthia Guy, Manal F. Abdelmalek, Anna Mae Diehl, and Cynthia A. Moylan. “Serum Metabolites Are Associated With HFpEF in Biopsy-Proven Nonalcoholic Fatty Liver Disease.J Am Heart Assoc 12, no. 14 (July 18, 2023): e029873. https://doi.org/10.1161/JAHA.123.029873.
Wegermann K, Fudim M, Henao R, Howe CF, McGarrah R, Guy C, et al. Serum Metabolites Are Associated With HFpEF in Biopsy-Proven Nonalcoholic Fatty Liver Disease. J Am Heart Assoc. 2023 Jul 18;12(14):e029873.
Wegermann, Kara, et al. “Serum Metabolites Are Associated With HFpEF in Biopsy-Proven Nonalcoholic Fatty Liver Disease.J Am Heart Assoc, vol. 12, no. 14, July 2023, p. e029873. Pubmed, doi:10.1161/JAHA.123.029873.
Wegermann K, Fudim M, Henao R, Howe CF, McGarrah R, Guy C, Abdelmalek MF, Diehl AM, Moylan CA. Serum Metabolites Are Associated With HFpEF in Biopsy-Proven Nonalcoholic Fatty Liver Disease. J Am Heart Assoc. 2023 Jul 18;12(14):e029873.
Journal cover image

Published In

J Am Heart Assoc

DOI

EISSN

2047-9980

Publication Date

July 18, 2023

Volume

12

Issue

14

Start / End Page

e029873

Location

England

Related Subject Headings

  • Stroke Volume
  • Retrospective Studies
  • Non-alcoholic Fatty Liver Disease
  • Lipids
  • Humans
  • Heart Failure
  • Cysteine
  • Biopsy
  • Adult
  • 3201 Cardiovascular medicine and haematology